Nandrolone supplementation does not improve functional recovery in an aged animal model of volumetric muscle loss injury
- 3 February 2022
- journal article
- research article
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 16 (4) , 367-379
Abstract
Aging hinders the effectiveness of regenerative medicine strategies targeting the repair of volumetric muscle loss (VML) injury. Anabolic steroids have been shown to improve several factors which contribute to the age-related decline in muscle's regenerative capacity. In this study, the impact of exogenous nandrolone decanoate (ND) administration on the effectiveness of a VML regenerative repair strategy was explored using an aged animal model. Unilateral tibialis anterior VML injuries were repaired in 18-month-aged animal models (male Fischer 344 rat) using decellularized human skeletal muscle scaffolds supplemented with autologous minced muscle. The contralateral limb was left untreated/uninjured. Following repair, ND(+) or a carrier control (ND−) was delivered via weekly injection for a period of 8 weeks. At 8 weeks, muscle isometric torque, gene expression, and tissue structure were assessed. ND(+) treatment did not improve contractile torque recovery following VML repair when compared to carrier only ND(−) injection controls. Peak isometric torque in the ND(+) VML repair group remained significantly below contralateral uninjured control values (4.69 ± 1.18vs. 7.46 ± 1.53 N mm/kg) and was statistically indistinguishable from carrier only ND(−) VML repair controls (4.47 ± 1.18 N mm/kg). Gene expression for key myogenic genes (Pax7, MyoD, MyoG, IGF-1) were not significantly elevated in response to ND injection, suggesting continued age related myogenic impairment even in the presence of ND(+) treatment. ND injection did reduce the histological appearance of fibrosis at the site of VML repair, and increased expression of the collagen III gene, suggesting some positive effects on repair site matrix regulation. Overall, the results presented in this study suggest that a decline in regenerative capacity with aging may present an obstacle to regenerative medicine strategies targeting VML injury and that the delivery of anabolic stimuli via ND administration was unable to overcome this decline.Keywords
Funding Information
- National Institutes of Health
This publication has 50 references indexed in Scilit:
- A comprehensive assessment of mitochondrial protein synthesis and cellular proliferation with age and caloric restrictionAging Cell, 2011
- Constitutive Expression of Insulin Receptor Substrate (IRS)-1 Inhibits Myogenic Differentiation through Nuclear Exclusion of Foxo1 in L6 MyoblastsPLOS ONE, 2011
- Repair of Traumatic Skeletal Muscle Injury with Bone-Marrow-Derived Mesenchymal Stem Cells Seeded on Extracellular MatrixTissue Engineering Part A, 2010
- Clinical Application of an Acellular Biologic Scaffold for Surgical Repair of a Large, Traumatic Quadriceps Femoris Muscle DefectOrthopedics, 2010
- Testosterone Supplementation Reverses Sarcopenia in Aging through Regulation of Myostatin, c-Jun NH2-Terminal Kinase, Notch, and Akt Signaling PathwaysEndocrinology, 2010
- Combat Wounds in Operation Iraqi Freedom and Operation Enduring FreedomJournal of Trauma: Injury, Infection & Critical Care, 2008
- Niche Regulation of Muscle Satellite Cell Self-Renewal and DifferentiationCell Stem Cell, 2008
- High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in ratsAPMIS, 2005
- Aging, Stem Cells and Tissue Regeneration: Lessons from MuscleCell Cycle, 2005
- FREE AUTO‐ AND HOMOGRAFTS OF MUSCLE TISSUE IN EXPERIMENTS ON ANIMALSAnnals of the New York Academy of Sciences, 1965